Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoma, NOS”

11,085 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 11,085 results

Not applicableStudy completedNCT01789060
What this trial is testing

P-AKT Expression on Clinical Outcomes in Malignant Lymphoma

Who this might be right for
Malignant LymphomaP13K-AKT Pathway Deregulation
Samsung Medical Center 262
Very early researchActive Not RecruitingNCT03684980
What this trial is testing

LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma

Who this might be right for
Central Nervous System Lymphoma
Memorial Sloan Kettering Cancer Center 58
Early research (Phase 1)Not Yet RecruitingNCT07113496
What this trial is testing

RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies

Who this might be right for
Relapsed or Refractory B-cell Hematologic MalignanciesB-cell Acute Lymphoblastic Leukemia (B-ALL)Multiple Myeloma (MM)+3 more
The First Affiliated Hospital with Nanjing Medical University 27
Post-approval studies (Phase 4)UnknownNCT02576327
What this trial is testing

A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Vomiting
Jun Zhu 130
Testing effectiveness (Phase 2)UnknownNCT04296786
What this trial is testing

Sintilimab Plus Chidamide in the Treatment of Relapsed and Refractory Cutaneous T-cell Lymphoma: a Multicenter Phase II Study

Who this might be right for
Cutaneous T-cell Lymphoma
Peking Union Medical College Hospital 52
Testing effectiveness (Phase 2)WithdrawnNCT00005969
What this trial is testing

Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's Disease

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00784017
What this trial is testing

Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic Leukaemia

Who this might be right for
Acute Lymphoblastic Leukemia
medac GmbH 199
Not applicableNot Yet RecruitingNCT07409168
What this trial is testing

Multi-modal Fusion Model and Deep Learning for Predicting Treatment Response in NKTCL

Who this might be right for
Natural Killer/T-cell Lymphoma
Sun Yat-sen University 100
Testing effectiveness (Phase 2)Looking for participantsNCT06249191
What this trial is testing

Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaHigh Grade B-Cell Lymphoma
OHSU Knight Cancer Institute 30
Not applicableEnded earlyNCT01761682
What this trial is testing

Acute Lymphoblastic Leukemia Registry at Asan Medical Center

Who this might be right for
Leukemia, Acute LymphoblasticPrecursor B-Cell Lymphoblastic LeukemiaLeukemia, Biphenotypic, Acute+2 more
Asan Medical Center 200
Not applicableLooking for participantsNCT07176624
What this trial is testing

The PRE-VAIL Study

Who this might be right for
ARDS (Moderate or Severe)Prone PositionEnteral Nutrition Feeding+1 more
The First Hospital of Jilin University 259
Early research (Phase 1)Study completedNCT00644124
What this trial is testing

Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Sanofi 25
Not applicableStudy completedNCT02184442
What this trial is testing

The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B

Who this might be right for
SevereSymptomaticCalcific Aortic Stenosis
Edwards Lifesciences 560
Testing effectiveness (Phase 2)Ended earlyNCT00126243
What this trial is testing

Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's Lymphoma

Who this might be right for
AIDS Related Lymphoma
French National Agency for Research on AIDS and Viral Hepatitis 60
Not applicableUnknownNCT04755478
What this trial is testing

LUS to Assess Lung Injury After Lung Lobectomy

Who this might be right for
Lung NeoplasmAdult ALLLung Injury+6 more
Hospital General Universitario de Valencia 30
Testing effectiveness (Phase 2)Study completedNCT00048555
What this trial is testing

Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Biogen 90
Early research (Phase 1)Ended earlyNCT02292225
What this trial is testing

Duvelisib With Obinutuzumab in Patients With CLL/SLL Previously Treated With a BTKi (SYNCHRONY)

Who this might be right for
Lymphocytic Leukemia, ChronicLymphoma, Small Lymphocytic
SecuraBio 3
Early research (Phase 1)WithdrawnNCT03605589
What this trial is testing

Pembro + Blina Combination in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Leukemia or Lymphoma

Who this might be right for
Leukemia, B-cellLymphoma, B-Cell
Children's Hospital Medical Center, Cincinnati
Testing effectiveness (Phase 2)Study completedNCT02500550
What this trial is testing

Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Kiadis Pharma 15
Testing effectiveness (Phase 2)Looking for participantsNCT07341191
What this trial is testing

Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy

Who this might be right for
Mantle Cell Lymphoma
Canadian Cancer Trials Group 40
Load More Results